A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

NCT01489696 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular
Healthy Subjects
Pharmacokinetics

Interventions

DRUG: mirabegron
DRUG: tamsulosin

Sponsor

Astellas Pharma Inc